- Home
- CREV vs MTNB Comparison
CREV vs MTNB Comparison
Compare CREV & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREV
- MTNB
- Stock Information
- Founded
- CREV 2007
- MTNB 2013
- Country
- CREV Ireland
- MTNB United States
- Employees
- CREV N/A
- MTNB N/A
- Industry
- CREV
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- CREV
- MTNB Health Care
- Exchange
- CREV Nasdaq
- MTNB Nasdaq
- Market Cap
- CREV 6.0M
- MTNB 5.2M
- IPO Year
- CREV N/A
- MTNB N/A
- Fundamental
- Price
- CREV $4.19
- MTNB $0.98
- Analyst Decision
- CREV
- MTNB Hold
- Analyst Count
- CREV 0
- MTNB 1
- Target Price
- CREV N/A
- MTNB N/A
- AVG Volume (30 Days)
- CREV 705.7K
- MTNB 87.6K
- Earning Date
- CREV 05-14-2025
- MTNB 08-13-2025
- Dividend Yield
- CREV N/A
- MTNB N/A
- EPS Growth
- CREV N/A
- MTNB N/A
- EPS
- CREV N/A
- MTNB N/A
- Revenue
- CREV $39,261,077.00
- MTNB N/A
- Revenue This Year
- CREV $40.76
- MTNB N/A
- Revenue Next Year
- CREV $86.18
- MTNB N/A
- P/E Ratio
- CREV N/A
- MTNB N/A
- Revenue Growth
- CREV 41.52
- MTNB N/A
- 52 Week Low
- CREV $2.00
- MTNB $0.47
- 52 Week High
- CREV $14.19
- MTNB $9.39
- Technical
- Relative Strength Index (RSI)
- CREV 61.02
- MTNB 53.81
- Support Level
- CREV $4.36
- MTNB $0.91
- Resistance Level
- CREV $5.99
- MTNB $1.04
- Average True Range (ATR)
- CREV 0.66
- MTNB 0.06
- MACD
- CREV 0.12
- MTNB -0.00
- Stochastic Oscillator
- CREV 61.78
- MTNB 47.06
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.